Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.

BACKGROUND Vasopressin receptor-mediated vasoconstriction is considered to be involved in the pathogenesis of organ failure in acute-on-chronic liver failure (ACLF). PATIENTS AND METHODS We studied the association between six single nucleotide polymorphisms (SNPs) of the vasopressin 1a receptor gene and the development of organ failure in 826 patients admitted for acute decompensation of liver cirrhosis (n=641) or ACLF (n=185). RESULTS No associations were found for SNPs with the presence of circulatory or renal failure. A C>T mutation in SNP rs7308855 and a T>A mutation in SNP rs7298346 showed an association with the presence of coagulation failure in the entire population (n=61, P=0.024 and 0.060, respectively) and in the subgroup of patients with ACLF (n=44, P=0.081 and 0.056, respectively). CONCLUSION Genetic variation in the vasopressin 1a receptor was found not to be associated with circulatory or renal failure, but with the presence of coagulation failure in patients with acute decompensation of liver cirrhosis and ACLF.

[1]  R. Moreau,et al.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.

[2]  R. Moreau,et al.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. , 2014, Journal of hepatology.

[3]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[4]  O. Melander,et al.  Relation between human vasopressin 1a gene variance, fat intake, and diabetes. , 2009, The American journal of clinical nutrition.

[5]  K. Sugimoto,et al.  Association of novel promoter single nucleotide polymorphisms in vasopressin V1a receptor gene with essential hypertension in nonobese Japanese , 2007, Journal of Human Hypertension.

[6]  G. Tsujimoto,et al.  V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Yasujima,et al.  Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness , 2006, Journal of clinical laboratory analysis.

[8]  L. Chauvelot‐Moachon,et al.  Coagulation disorders in patients with cirrhosis and severe sepsis , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[9]  G. Robertson Antidiuretic hormone. Normal and disordered function. , 2001, Endocrinology and metabolism clinics of North America.

[10]  S. Kunapuli,et al.  Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Zijian Xie,et al.  Heterogeneity of the aggregation response of human platelets to arginine vasopressin , 1995, American journal of hematology.

[12]  L. Share Role of vasopressin in cardiovascular regulation. , 1988, Physiological reviews.

[13]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[14]  J. Filep,et al.  Mechanism of vasopressin-induced platelet aggregation. , 1987, Thrombosis research.

[15]  V. Arroyo,et al.  Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. , 1980, Gastroenterology.

[16]  R. Haslam,et al.  Aggregation of human blood platelets by vasopressin. , 1972, The American journal of physiology.